THERAPY: Avoiding treatment failures associated with HCV resistance

    loading  Checking for direct PDF access through Ovid

Abstract

Treatment failure associated with HCV resistance to newly developed direct-acting antiviral agents is not an uncommon occurrence and poses a substantial problem to clinicians trying to re-treat patients who have failed available interferon-free treatments. A new study suggests that host-targeted agents are the way forward, but is this approach really feasible?

Related Topics

    loading  Loading Related Articles